For Medical Grand Round on Fulminant Diabetes. Format: 20 Slides (Approx. 45–50 minutes) Target Guidelines: Japanese Dermatological Association / Japan Diabetes Society (JDS) Diagnostic Criteria, American Diabetes Association (ADA) Classification Standards. Section 1: The Clinical Encounter (Case Presentation) • Slide 1: Title Slide • Content: Title (e.g., Fulminant Type 1 Diabetes: A Hyper-Acute Endocrine Emergency), Presenter Name, Institution, and Date. • Slide 2: Case Presentation – Chief Complaint & HPI • Content: A healthy 28-year-old presenting with severe nausea, vomiting, abdominal pain, and tachypnea. Flulike prodromal symptoms (fever, upper respiratory symptoms) occurred just 48 hours prior. • Slide 3: Physical Examination & Initial Vitals • Content: Tachycardia, hypotension, and deep, rapid respirations (Kussmaul breathing). Fruity odor on breath. Alert but lethargic. • Slide 4: Emergent Laboratory Investigations • Content: Severe metabolic acidosis (pH < 7.1, HCO₃⁻ < 10 mEq/L). Marked hyperglycemia (Blood glucose > 16.0 mmol/L or > 288 mg/dL) with dense ketonuria. • Crucial Catch: HbA1c is paradoxically near-normal (< 8.7% or < 72 mmol/mol), completely out of proportion to the severe hyperglycemia. Section 2: Defining the Pathology • Slide 5: The Diagnostic Paradox & Differential Diagnosis • Content: Comparison table contrasting Classical Autoimmune T1D, Type 2 DKA, and Fulminant T1D. Highlight why the near-normal HbA1c misleads clinicians into missing the diagnosis. • Slide 6: Definitive Diagnostic Criteria (JDS Guidelines) • Content: Bold the official diagnostic criteria triad: 1. Occurrence of diabetic ketosis/ketoacidosis within ~1 week of symptom onset. 2. Plasma glucose ≥ 16.0 mmol/L AND HbA1c < 8.7% at first presentation. 3. Urinary C-peptide excretion < 10 μg/day (or fasting serum C-peptide < 0.3 ng/mL), demonstrating complete endogenous insulin depletion. • Citation Placeholder: [Insert Citation: Imagawa et al., JDS Committee Report on Fulminant Type 1 Diabetes] • Slide 7: Epidemiology and Demographics • Content: Originally identified and primarily reported in East Asian populations, though globally underdiagnosed. Accounts for ~20% of acute-onset T1D cases in Japan. Often associated with pregnancy (gestational onset carries extremely high fetal mortality).
For Medical Grand Round on Fulminant Diabetes.
Format: 20 Slides (Approx. 45–50 minutes)
Target Guidelines: Japanese Dermatological Association / Japan Diabetes Society (JDS) Diagnostic Criteria, American Diabetes Association (ADA) Classification Standards.
Section 1: The Clinical Encounter (Case Presentation)
• Slide 1: Title Slide
• Content: Title (e.g., Fulminant Type 1 Diabetes: A Hyper-Acute Endocrine Emergency), Presenter Name, Institution, and Date.
• Slide 2: Case Presentation – Chief Complaint & HPI
• Content: A healthy 28-year-old presenting with severe nausea, vomiting, abdominal pain, and tachypnea. Flulike prodromal symptoms (fever, upper respiratory symptoms) occurred just 48 hours prior.
• Slide 3: Physical Examination & Initial Vitals
• Content: Tachycardia, hypotension, and deep, rapid respirations (Kussmaul breathing). Fruity odor on breath. Alert but lethargic.
• Slide 4: Emergent Laboratory Investigations
• Content: Severe metabolic acidosis (pH < 7.1, HCO₃⁻ < 10 mEq/L). Marked hyperglycemia (Blood glucose > 16.0 mmol/L or > 288 mg/dL) with dense ketonuria.
• Crucial Catch: HbA1c is paradoxically near-normal (< 8.7% or < 72 mmol/mol), completely out of proportion to the severe hyperglycemia.
Section 2: Defining the Pathology
• Slide 5: The Diagnostic Paradox & Differential Diagnosis
• Content: Comparison table contrasting Classical Autoimmune T1D, Type 2 DKA, and Fulminant T1D. Highlight why the near-normal HbA1c misleads clinicians into missing the diagnosis.
• Slide 6: Definitive Diagnostic Criteria (JDS Guidelines)
• Content: Bold the official diagnostic criteria triad:
1. Occurrence of diabetic ketosis/ketoacidosis within ~1 week of symptom onset.
2. Plasma glucose ≥ 16.0 mmol/L AND HbA1c < 8.7% at first presentation.
3. Urinary C-peptide excretion < 10 μg/day (or fasting serum C-peptide < 0.3 ng/mL), demonstrating complete endogenous insulin depletion.
• Citation Placeholder: [Insert Citation: Imagawa et al., JDS Committee Report on Fulminant Type 1 Diabetes]
• Slide 7: Epidemiology and Demographics
• Content: Originally identified and primarily reported in East Asian populations, though globally underdiagnosed. Accounts for ~20% of acute-onset T1D cases in Japan. Often associated with pregnancy (gestational onset carries extremely high fetal mortality).
Created using ChatSlide
This presentation focuses on the critical aspects of diagnosing and understanding fulminant Type 1 Diabetes. It begins by recognising hyper-acute presentations, including flu-like symptoms and the significance of near-normal HbA1c levels. It then confirms the diagnosis using a diagnostic table and the JDS triad, alongside relevant epidemiological data. Finally, it explains the rapid failure of beta-cells, detailing the mechanisms of insulitis, viral triggers, and the classification of ADA...